Schedule 13G ownership disclosure
Denali Therapeutics Inc
Security class unavailable · CUSIP: 24823R105
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,207,542
- Percent of class
- 6.4600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-018678
- Form type
- SC 13G
- Filer
- Denali Therapeutics Inc.
- CIK
- CIK 1714899
- Filed
- Feb 12, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership